(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CORDAVIS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CORDAVIS

ST13

US500000097980606

Class

5, 40

Filing

97980606

Registration

8024186

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

11/12/2025

Trademark type

Word

Nice classes

5, 40

Filing date

01/19/2023

Registration date

11/11/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/11/2025

Last transaction

11/12/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

08/23/2023

First use in commerce

08/23/2023

Drawing code

4

Owner type

77

Owner location

DUBLIN, IE

Examiner

CHOI,REBECCA EJ

Law office

M90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

CORDAVIS LIMITED
North 53 TAOH Limited

Representatives

Kelly A. Donahue VERRILL DANA, LLP

Technical classification

Nice Classes

Class 5Class 40

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical productsprescription drugs and biological preparations for treating chronic diseasesrespiratory diseasesarthritic diseasesfor ophthalmological usefor the prevention of high blood pressure; Pharmaceutical productsgeneric prescription drugs for treating chronic diseasesrespiratory diseasesarthritic diseasesfor ophthalmological usefor the prevention of high blood pressure

Class 40

Custom manufacture of pharmaceutical products; Custom manufacture of generic prescription drugs

Publications

History of USPTO decisions and trademark events.

29 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/11/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

11/11/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

10/20/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/20/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/28/2025

DPCC

DIVISIONAL PROCESSING COMPLETE

08/28/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/18/2025

IUAF

USE AMENDMENT FILED

02/07/2025

DRRR

DIVISIONAL REQUEST RECEIVED

02/07/2025

EISU

TEAS STATEMENT OF USE RECEIVED

02/07/2025

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

02/07/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/20/2024

EX1G

SOU EXTENSION 1 GRANTED

06/20/2024

EXT1

SOU EXTENSION 1 FILED

06/20/2024

EEXT

SOU TEAS EXTENSION RECEIVED

06/20/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/12/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/16/2024

PUBO

PUBLISHED FOR OPPOSITION

01/16/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/27/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/24/2023

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

10/24/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

10/24/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/24/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

10/24/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/24/2023

DOCK

ASSIGNED TO EXAMINER

10/17/2023

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/24/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/10/2023

NWAP

NEW APPLICATION ENTERED

01/23/2023

Continuous trademark protection

Get notified about every new filing that threatens CORDAVIS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.